How Triomics Uses AI To Help Doctors Treat Cancer More Quickly
How Triomics Uses AI To Help Doctors Treat Cancer More Quickly
Publish Date: 2026-06-03 07:00:00
Source Domain: www.forbes.com
-
Doctors’ Information Overload: Clinicians face immense pressure to process extensive patient records, often spanning hundreds of pages, which hampers timely diagnosis and treatment for cancer patients.
-
Triomics’ AI Solution: Triomics, a New York-based tech startup, aims to alleviate this burden with its AI platform, created to reduce time spent on information processing and improve decision-making for oncologists.
-
Enhanced Efficiency: Triomics’ AI, based on specialized large language models, processes patient records efficiently, leading to a 67% reduction in chart review time and a 40% improvement in matching patients to clinical trials.
-
Rapid Expansion: Since its 2021 inception, Triomics has rapidly grown, now partnering with centers treating around 15% of American cancer patients, including leading cancer centers like Memorial Sloan Kettering and the Mount Sinai Tisch Cancer Center.
-
Focus on Accuracy and Transparency: The platform emphasizes accuracy and transparency by providing verifiable sources for its outputs and ensuring doctors can meet compliance needs, rather than relying on implicit trust in AI.
-
Revenue and Growth: Triomics’ revenue is in seven figures, and the company plans to expand its audit and reporting services, supported by a £22 million Series B funding round, surpassing $36 million in total funding.
-
Strategic Investment: The Series B funding, led by Battery Ventures, includes participation from Nexus Venture Partners, Lightspeed, Y Combinator, and specialists from oncology and health informatics providing strategic support.
-
Future Plans: The company intends to scale through recruiting engineering and clinical experts while further improving its AI models and expanding its services.
